Weixi Cao - Search Results

Year	Number of Results
2003	1
2006	1
2007	1
2009	2
2010	1
2011	5
2012	3
2013	4
2015	2
2017	2
2021	0

1

Depression of oncogenecity by dephosphorylating and degrading BCR-ABL.

Gao M, Huang ZL, Tao K, Xiao Q, Wang X, Cao WX, Xu M, Hu J, Feng WL. Gao M, et al. Oncotarget. 2017 Jan 10;8(2):3304-3314. doi: 10.18632/oncotarget.13754. Oncotarget. 2017. PMID: 27926512 Free PMC article.

2

Induction of apoptosis by directing oncogenic Bcr-Abl into the nucleus.

Huang ZL, Gao M, Li QY, Tao K, Xiao Q, Cao WX, Feng WL. Huang ZL, et al. Oncotarget. 2013 Dec;4(12):2249-60. doi: 10.18632/oncotarget.1339. Oncotarget. 2013. PMID: 24158537 Free PMC article.

3

Inhibition of BCR/ABL protein expression by miR-203 sensitizes for imatinib mesylate.

Li Y, Yuan Y, Tao K, Wang X, Xiao Q, Huang Z, Zhong L, Cao W, Wen J, Feng W. Li Y, et al. Among authors: cao w. PLoS One. 2013 Apr 16;8(4):e61858. doi: 10.1371/journal.pone.0061858. Print 2013. PLoS One. 2013. PMID: 23613955 Free PMC article.

4

Heat shock protein-70 neutralizes apoptosis inducing factor in Bcr/Abl expressing cells.

Wang F, Dai AY, Tao K, Xiao Q, Huang ZL, Gao M, Li H, Wang X, Cao WX, Feng WL. Wang F, et al. Cell Signal. 2015 Oct;27(10):1949-55. doi: 10.1016/j.cellsig.2015.06.006. Epub 2015 Jul 9. Cell Signal. 2015. PMID: 26165468

5

Blockade of Y177 and Nuclear Translocation of Bcr-Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells.

Li Q, Huang Z, Gao M, Cao W, Xiao Q, Luo H, Feng W. Li Q, et al. Among authors: cao w. Int J Mol Sci. 2017 Mar 2;18(3):537. doi: 10.3390/ijms18030537. Int J Mol Sci. 2017. PMID: 28257089 Free PMC article.

6

miR-29b suppresses CML cell proliferation and induces apoptosis via regulation of BCR/ABL1 protein.

Li Y, Wang H, Tao K, Xiao Q, Huang Z, Zhong L, Cao W, Wen J, Feng W. Li Y, et al. Among authors: cao w. Exp Cell Res. 2013 May 1;319(8):1094-101. doi: 10.1016/j.yexcr.2013.02.002. Epub 2013 Feb 18. Exp Cell Res. 2013. PMID: 23428668

7

ABL SH3 mutant inhibits BCR-ABL activity and increases imatinib sensitivity by targeting RIN1 protein in CML cell.

Liu X, Li Y, Wen L, Tao K, Xiao Q, Cao W, Huang Z, Gao M, Li H, Wang F, Feng W. Liu X, et al. Among authors: cao w. Cancer Lett. 2015 Dec 1;369(1):222-8. doi: 10.1016/j.canlet.2015.08.017. Epub 2015 Aug 28. Cancer Lett. 2015. PMID: 26321052

8

Proteomic-based identification of Apg-2 as a therapeutic target for chronic myeloid leukemia.

Li Y, Chen X, Shi M, Wang H, Cao W, Wang X, Li C, Feng W. Li Y, et al. Among authors: cao w. Cell Signal. 2013 Dec;25(12):2604-12. doi: 10.1016/j.cellsig.2013.08.023. Epub 2013 Sep 3. Cell Signal. 2013. PMID: 24012954

9

Selective leukemia cell death by activation of the double-stranded RNA-dependent protein kinase PKR.

Li YJ, Zeng JM, Huang SF, Wang XZ, Zhao SQ, Bai WJ, Cao WX, Huang ZG, Feng WL. Li YJ, et al. Int J Mol Med. 2011 Aug;28(2):215-22. doi: 10.3892/ijmm.2011.666. Epub 2011 Apr 4. Int J Mol Med. 2011. PMID: 21468538

10

Construction and expression of humanized chimeric T cell receptor specific for chronic myeloid leukemia cells.

Wang D, Zhang L, Li Y, Wang H, Xiao Q, Cao W, Feng W. Wang D, et al. Among authors: cao w. Biotechnol Lett. 2012 Jul;34(7):1193-201. doi: 10.1007/s10529-012-0896-5. Epub 2012 Mar 24. Biotechnol Lett. 2012. PMID: 22447097

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results